Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.
Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.
Identifying Technologies Requiring Innovation and Support
Virtual R&D proposal for UK SPINE
Offering clarity to the scope of the term ‘complex medicines’
Chris Molloy, Chief Executive Officer of the Medicines Discovery Catapult will be stepping down in September 2021 after five years in the role.
Psychiatric drug discovery must be a truly collaborative process if it is to be successful.
While student perceptions of careers in science may come with a lack of diversity, the Covid-19 pandemic has highlighted the important contributions made by scientists and healthcare professionals…
Medicines Discovery Catapult’s newly appointed Chief Business Officer, Dr Nicola Heron MBA sets out her intention to support up-and-coming innovators…
See how we can help support you with your next drug discovery project.
Speak to us
